Amedisys, Inc. (NASDAQ:AMED) Shares Bought by Quarry LP

Quarry LP boosted its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 48.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,647 shares of the health services provider's stock after acquiring an additional 13,028 shares during the period. Amedisys comprises 0.5% of Quarry LP's investment portfolio, making the stock its 17th biggest holding. Quarry LP owned about 0.12% of Amedisys worth $3,600,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Blue Trust Inc. boosted its holdings in Amedisys by 55.1% in the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after purchasing an additional 124 shares in the last quarter. HBW Advisory Services LLC purchased a new position in shares of Amedisys in the 4th quarter valued at $38,000. Versant Capital Management Inc raised its stake in Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock worth $41,000 after acquiring an additional 183 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in Amedisys in the fourth quarter valued at $55,000. Finally, Vestcor Inc acquired a new stake in shares of Amedisys during the fourth quarter worth about $73,000. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Stock Performance

AMED traded up $0.30 during trading on Thursday, reaching $95.20. The company's stock had a trading volume of 576,611 shares, compared to its average volume of 408,312. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The company's fifty day moving average price is $92.41 and its 200-day moving average price is $91.78. Amedisys, Inc. has a 52-week low of $82.15 and a 52-week high of $99.39. The company has a market capitalization of $3.12 billion, a price-to-earnings ratio of 37.78, a price-to-earnings-growth ratio of 1.78 and a beta of 0.89.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. The firm had revenue of $594.78 million for the quarter, compared to the consensus estimate of $597.43 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The company's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.03 earnings per share. On average, equities analysts forecast that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on AMED shares. Royal Bank of Canada reiterated an "outperform" rating and set a $100.00 price target on shares of Amedisys in a research note on Wednesday, April 16th. Stephens restated an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a research report on Tuesday, March 4th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, Amedisys has an average rating of "Hold" and an average price target of $100.75.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.